- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Nephro Care India Limited has submitted its Integrated Governance report for the quarter ended December 31, 2024, in compliance with recent SEBI and NSE circulars. The company’s listing on the NSE EMERGE platform occurred on July 5, 2024, exempting it from some corporate governance requirements. Notably, the report indicates no investor complaints were pending, received, or unresolved during the quarter, reflecting strong stakeholder engagement. This update may enhance investor confidence, presenting a positive outlook given the company's proactive compliance and governance strategies.